KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortizationAmortizationCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in IntangiblesChange in IntangiblesChange in TaxesChange in TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Dividends Paid - CommonDividends Paid - CommonExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeSales of Property, Plant and EquipmentSales of Property, Plant and EquipmentShares IssuedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Astrazeneca (AZN) Cash from Investing Activities (2018 - 2026)

Astrazeneca has reported Cash from Investing Activities over the past 16 years, most recently at -$1.8 billion for Q1 2026.

  • For Q1 2026, Cash from Investing Activities fell 43.02% year-over-year to -$1.8 billion; the TTM value through Mar 2026 reached -$7.3 billion, down 7.73%, while the annual FY2025 figure was -$6.8 billion, 14.69% up from the prior year.
  • Cash from Investing Activities for Q1 2026 was -$1.8 billion at Astrazeneca, down from -$1.4 billion in the prior quarter.
  • Over five years, Cash from Investing Activities peaked at -$168.0 million in Q1 2022 and troughed at -$2.9 billion in Q2 2024.
  • A 5-year average of -$1.5 billion and a median of -$1.4 billion in 2025 define the central range for Cash from Investing Activities.
  • Biggest five-year swings in Cash from Investing Activities: crashed 641.67% in 2023 and later skyrocketed 48.07% in 2025.
  • Year by year, Cash from Investing Activities stood at -$800.0 million in 2022, then skyrocketed by 35.0% to -$520.0 million in 2023, then plummeted by 127.12% to -$1.2 billion in 2024, then dropped by 22.44% to -$1.4 billion in 2025, then dropped by 23.93% to -$1.8 billion in 2026.
  • Business Quant data shows Cash from Investing Activities for AZN at -$1.8 billion in Q1 2026, -$1.4 billion in Q4 2025, and -$2.0 billion in Q3 2025.